Concepedia

Dušanka Martinović Kaliterna

DM

Statistics

Publications

15

Citations

902

H-Index

14

Active since

2001

Affiliations

University of Split(Current)

Dušanka Martinović Kaliterna is an author at University of Split specializing in medicine, autoimmune disease, and scleroderma.

Top concepts

Publications per year

2001–2020

15

Publications

15

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 612 citations · Full text

, , +3

Efficacy and Safety of Tocilizumab for the Treatment of Systemic Sclerosis: Results from a Phase 3 Randomized Controlled Trial

Dinesh Khanna, Celia J. F. Lin, Masataka Kuwana et al. · Arthritis & Rheumatism · 2018 · 33 citations

, , +6

Infectious disease as aetiological factor in the pathogenesis of systemic sclerosis.

Mislav Radić, Dušanka Martinović Kaliterna, Josipa Radić · PubMed · 2010 · 30 citations

Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis?

Mislav Radić, Dušanka Martinović Kaliterna, Damir Bonacin et al. · Rheumatology International · 2012 · 29 citations

, , +12

The level of anti-topoisomerase I antibodies highly correlates with metacarpophalangeal and proximal interphalangeal joints flexion contractures in patients with systemic sclerosis.

Mislav Radić, Dušanka Martinović Kaliterna, Dragan Ljutić · PubMed · 2006 · 26 citations

1–5 of 15